Prise en charge du diabète de type 1 au Luxembourg en 2017 en 3 points

Objectives

The framework aims to provide lifelong, comprehensive care for people with type 1 diabetes, treating the condition as chronic and requiring continuing management from diagnosis. It seeks to normalise and stabilise blood glucose through insulin-based treatment, support active self-management by patients and, where relevant, families or educational carers, and reduce early eye, kidney, neurological and cardiovascular complications.[1][2][3]

• Provide care through a recommended pathway combining clinical and biological assessment with ongoing follow-up.[1][2]
• Ensure insulin regimens are proposed by a doctor specialising in type 1 diabetes treatment.[2]
• Develop patients’ and carers’ capacity to manage diabetes, including recognition of hypoglycaemia and practical self-management competence.[2][3]
• Deliver therapeutic education covering insulin treatment and monitoring, nutrition, physical activity, psychological support, vaccination and relevant lifestyle risks.[2][3]
• Prevent disabling foot complications and amputations through routine examination, self-examination education for people at substantial risk, and podiatry support.[2][3]

Implementation

Care is organised as lifelong specialist multidisciplinary support, combining medical treatment with structured assessment, therapeutic education, psychosocial consideration and prevention of complications. The delivery model requires assessment at initial, annual and quarterly reviews, with additional examinations and biological tests according to clinical need, individual risk and glycaemic balance.[4][2][3]

• Assess diabetes history; family and personal history; current treatment; complications; lifestyle; psychosocial circumstances; economic factors; and risks affecting glycaemic regulation or treatment follow-up.[1][4]
• Measure height, weight, body mass index, blood pressure and general clinical status at the specified review points.[4]
• Review thyroid function, injection or infusion sites, hypoglycaemia, diabetes self-management skills and physical activity according to the clinical assessment schedule and individual risk.[4][2]
• Examine retinal health through specialist assessment, and assess depression and eating disorders, particularly where clinically indicated or glycaemic control is unbalanced.[4]
• Assess nutritional knowledge and, where appropriate, alcohol, drug and tobacco use, contraception needs, and problems associated with driving motor vehicles.[4][2]
• Inspect the feet at every examination, including inspection, palpation of foot and tibial pulses, assessment of the Achilles reflex, proprioception, vibration and fine touch.[2]
• Teach foot self-examination where risk factors are substantial and use trained podiatry support as a core preventive component of care.[2][3]
• Request additional biological analyses and screen for other autoimmune disease when clinically appropriate; provide vaccinations according to need.[2]
• Deliver care through a team including a doctor, nurse, dietitian, psychologist, social worker and podiatrist, with specialist advice on insulin management, lifestyle, psychological support and foot care.[3]
• Involve the Scientific Council, the Health Directorate and the Luxembourg Diabetes Society through the named working group and expert contributors.[3]

The available material does not specify budgets, financing sources, resource requirements, formal outcome indicators, reporting arrangements, surveillance systems, accountability procedures or detailed governance responsibilities beyond the identified institutional and expert involvement.[1][4][2][3]

Monitoring & Evaluation

Monitoring is embedded in lifelong, multidisciplinary care for type 1 diabetes, combining scheduled clinical and biological review with additional assessment according to individual risk, clinical need and glycaemic balance. The available material focuses on patient-level follow-up rather than programme-level evaluation.[1][4][2][3]

• Monitor height, weight, body mass index, blood pressure and general clinical status at initial, annual and quarterly reviews.[4]
• Review thyroid status, insulin injection or infusion sites, hypoglycaemia, diabetes self-management competence and physical activity at the frequencies set out in the clinical assessment schedule.[4]
• Conduct biological analyses according to the indicated schedule, while allowing additional tests when clinically appropriate; the available excerpt does not reproduce the schedule or identify the individual analyses.[2]
• Assess retinal health through specialist examination, and screen for depression and eating disorders, including additional review where clinically indicated or where glycaemic control is unbalanced.[4]
• Assess diabetes history, treatment, complications, lifestyle, psychosocial circumstances, economic factors and risks that could affect glycaemic control or continuity of treatment follow-up.[1][4]
• Assess self-management skills, nutritional knowledge and physical activity, alongside relevant alcohol, drug and tobacco use, contraception needs and driving-related issues where appropriate.[2]
• Monitor feet at every examination through inspection and neurological and vascular assessment, and provide self-examination teaching where risk factors are substantial.[2]
• Use trained podiatry support as part of follow-up, with prevention of disabling amputations identified as an important purpose of foot care.[3]
• Screen for other autoimmune disease when indicated and provide vaccinations according to need.[2]

The material identifies specialist retinal examination, clinical review, biological testing and multidisciplinary input as care-monitoring mechanisms. It does not specify formal population surveillance, aggregate performance indicators, target thresholds, data systems, reporting cycles, public reporting arrangements, evaluation methods or accountability procedures.[4][2][3]

Costing & Financing

No explicit financial framework is provided. The available material does not specify programme costs, budgets, unit costs, financing sources, resource-mobilisation arrangements, funding gaps, affordability assessments or economic assumptions.[1][4][2][3]

• Identify a specialised multidisciplinary team including a doctor, nurse, dietitian, psychologist, social worker and podiatrist as part of lifelong support, but do not quantify the workforce, service-delivery resources or associated expenditure.[3]
• Provide specialist advice on insulin treatment and monitoring, lifestyle, psychological support and foot care, but do not identify the payer, funding mechanism or financial allocation for these services.[3]
• Require insulin regimens to be proposed by a doctor specialising in type 1 diabetes treatment, but do not state insulin prices, reimbursement arrangements, procurement mechanisms or patient costs.[2]
• Include specialist retinal examinations, biological analyses, vaccinations when needed and podiatry support in care, but do not provide cost estimates or budget lines for these activities.[4][2][3]